Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple Ascending Doses of Oral WCK 2349
NCT04874324
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Pharmacokinetics
Interventions
DRUG:
WCK 2349 Oral
OTHER:
Placebo Oral
Sponsor
Wockhardt